Genetics of monogenic autoinflammatory diseases: past successes, future challenges.

Nat Rev Rheumatol 2011 Jul 5;7(8):469-78. Epub 2011 Jul 5.

Inflammatory Disease Section, National Human Genome Research Institute, Building 10/Room 10C101B, 10 Center Drive, MSC 1849, Bethesda, MD 20892-1849, USA. aksentii@ exchange.nih.gov

The term autoinflammation was initially coined to distinguish disorders characterized by recurrent episodes of inflammation in the absence of high-titer autoantibodies and antigen-specific T cells from the more common autoimmune diseases. Although this concept originally applied to monogenic hereditary recurrent fevers, it has expanded over time to include polygenic (complex) autoinflammatory diseases. Understanding of the pathogenesis of autoinflammatory diseases has grown rapidly in the past decade owing to advances in genome research and technology. Genome-wide linkage analysis, positional cloning, homozygosity mapping and candidate gene screening have led to the identification of mutations in 12 genes that are associated with monogenic diseases. Genome-wide association studies have begun to elucidate the molecular basis of complex autoinflammatory diseases. The discovery of disease-causing genetic variants has defined autoinflammation as disorder within the innate immune system, implicating IL-1 as a master cytokine, and has led to a breakthrough in therapy, with IL-1 inhibitors producing rapid and sustained amelioration of symptoms. Despite major advances, however, a substantial number of patients have no mutations in the known autoinflammatory genes. The challenge now is to find the undiscovered genes, considering that most cases are sporadic or occur within small families. New approaches and tools such as next-generation sequencing are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2011.94DOI Listing
July 2011
15 Reads

Publication Analysis

Top Keywords

autoinflammatory diseases
16
complex autoinflammatory
8
diseases
6
autoinflammatory
5
despite major
4
homozygosity mapping
4
cloning homozygosity
4
mapping candidate
4
positional cloning
4
analysis positional
4
symptoms despite
4
major advances
4
screening led
4
identification mutations
4
mutations genes
4
led identification
4
amelioration symptoms
4
gene screening
4
advances substantial
4
candidate gene
4

References

(Supplied by CrossRef)

MF McDermott et al.
Cell 1999

J Galon et al.
Curr. Opin. Immunol. 2000

SL Masters et al.
Annu. Rev. Immunol. 2009

The International FMF Consortium et al.
Cell 1997

JP Drenth et al.
Nat. Genet. 1999

SM Houten et al.
Nat. Genet. 1999

HM Hoffman et al.
Nat. Genet. 2001

PJ Ferguson et al.
J. Med. Genet. 2005

I Aksentijevich et al.
N. Engl. J. Med. 2009

S Reddy et al.
N. Engl. J. Med. 2009

Similar Publications